NCT00090272View on ClinicalTrials.gov

A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)

PHASE3CompletedINTERVENTIONAL
Enrollment

952

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Colorectal Surgery
Interventions
DRUG

MK0826, ertapenem sodium

DRUG

Comparator: cefotetan

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00090272 - A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039) | Biotech Hunter | Biotech Hunter